{"ticker": "NLTX", "overview": {"cik": "1404644", "ticker": "NGNE", "name": "Neurogene Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000205", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-10-06", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000058", "price_sensitive": false}, {"form": "4", "date": "2026-10-02", "title": "FORM 4", "accession": "0001606302-26-000007", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-097193", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001493152-26-038383", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003430", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001404644-26-000059", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001404644-26-000056", "price_sensitive": true}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001543663-26-000017", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "FORM 4", "accession": "0001543663-26-000015", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001404644-26-000050", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001628280-26-046666", "price_sensitive": false}, {"form": "424B5", "date": "2026-06-30", "title": "Prospectus", "accession": "0001628280-26-046237", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-29", "title": "Material event", "accession": "0001404644-26-000046", "price_sensitive": true}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000010", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-06-16", "title": "FORM 3/A", "accession": "0001996804-26-000008", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001404644-26-000044", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001404644-26-000040", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001404644-26-000038", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001404644-26-000037", "price_sensitive": true}, {"form": "4", "date": "2026-05-08", "title": "FORM 4", "accession": "0001543663-26-000013", "price_sensitive": false}, {"form": "4", "date": "2026-05-07", "title": "FORM 4", "accession": "0001934412-26-000006", "price_sensitive": false}, {"form": "144", "date": "2026-05-06", "title": "Notice of proposed sale", "accession": "0001968582-26-000406", "price_sensitive": false}]}, "description": "NLTX trades as NLTX. Privy Trades holds 87 insider filings for the company, from September 2019 to August 2023. Across those, 7 insiders disclosed 8 open-market purchases totalling $38.48M against 28 sales totalling $438.20K. The most recent filing on record is dated 5 October 2023.", "exchange": null, "stats": {"buy_n": 8, "buy_sum": 38478766.0436, "sell_n": 28, "sell_sum": 438195.4082, "net": 38040570.6354, "insiders": 7, "first_date": "2019-09-11", "last_date": "2023-08-17"}, "metrics": {"ticker": "NLTX", "has_prices": false}, "trades": [{"id": "0001209191-23-052526", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123052526/0001209191-23-052526-index.htm", "trade_date": "2023-10-05", "timestamp": "2023-10-05", "mins": 1619448}, {"id": "0001209191-23-046351", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1463486.7308, "score": 60.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "NLTX lands a director's $1.5M", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123046351/0001209191-23-046351-index.htm", "trade_date": "2023-08-17", "timestamp": "2023-08-17", "mins": 1690008}, {"id": "0001209191-23-045611", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Interim CFO, Prin Acct Off", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 818.1432, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO takes $818 off the table in NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123045611/0001209191-23-045611-index.htm", "trade_date": "2023-08-11", "timestamp": "2023-08-11", "mins": 1698648}, {"id": "0001209191-23-035853", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Martin Babler", "who_key": "Babler Martin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123035853/0001209191-23-035853-index.htm", "trade_date": "2023-06-08", "timestamp": "2023-06-08", "mins": 1790808}, {"id": "0001209191-23-035861", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sarah B. Noonberg", "who_key": "Noonberg Sarah B.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123035861/0001209191-23-035861-index.htm", "trade_date": "2023-06-08", "timestamp": "2023-06-08", "mins": 1790808}, {"id": "0001209191-23-035866", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Rohan Palekar", "who_key": "PALEKAR ROHAN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123035866/0001209191-23-035866-index.htm", "trade_date": "2023-06-08", "timestamp": "2023-06-08", "mins": 1790808}, {"id": "0001209191-23-035869", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Todd E. Simpson", "who_key": "SIMPSON TODD E", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123035869/0001209191-23-035869-index.htm", "trade_date": "2023-06-08", "timestamp": "2023-06-08", "mins": 1790808}, {"id": "0001209191-23-036241", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123036241/0001209191-23-036241-index.htm", "trade_date": "2023-06-08", "timestamp": "2023-06-08", "mins": 1790808}, {"id": "0001209191-23-023100", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Priti Patel", "who_key": "Patel Priti", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "SELL", "amount": 2607.7711, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider offloads $3K of NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123023100/0001209191-23-023100-index.htm", "trade_date": "2023-04-03", "timestamp": "2023-04-03", "mins": 1885848}, {"id": "0001209191-23-006881", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Priti Patel", "who_key": "Patel Priti", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 8587.735999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Top exec sells $9K of NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123006881/0001209191-23-006881-index.htm", "trade_date": "2023-02-02", "timestamp": "2023-02-02", "mins": 1972248}, {"id": "0001209191-23-006886", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Principal Accounting Officer", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1980.3151999999998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Top exec sells $2K of NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123006886/0001209191-23-006886-index.htm", "trade_date": "2023-02-02", "timestamp": "2023-02-02", "mins": 1972248}, {"id": "0001209191-22-045667", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Principal Accounting Officer", "person_type": "EXEC", "person_label": "Execs", "action": "SELL", "amount": 1640.7669999999998, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite trims NLTX: $2K", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122045667/0001209191-22-045667-index.htm", "trade_date": "2022-08-10", "timestamp": "2022-08-10", "mins": 2225688}, {"id": "0001209191-22-044430", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Donna Cochener", "who_key": "Cochener Donna", "role": "General Counsel, SVP Legal", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122044430/0001209191-22-044430-index.htm", "trade_date": "2022-08-02", "timestamp": "2022-08-02", "mins": 2237208}, {"id": "0001209191-22-044432", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122044432/0001209191-22-044432-index.htm", "trade_date": "2022-08-02", "timestamp": "2022-08-02", "mins": 2237208}, {"id": "0001209191-22-044433", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Priti Patel", "who_key": "Patel Priti", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122044433/0001209191-22-044433-index.htm", "trade_date": "2022-08-02", "timestamp": "2022-08-02", "mins": 2237208}, {"id": "0001209191-22-044434", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Principal Accounting Officer", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122044434/0001209191-22-044434-index.htm", "trade_date": "2022-08-02", "timestamp": "2022-08-02", "mins": 2237208}, {"id": "0001209191-22-044435", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Carl Walkey", "who_key": "Walkey Carl", "role": "Senior Vice President", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122044435/0001209191-22-044435-index.htm", "trade_date": "2022-08-02", "timestamp": "2022-08-02", "mins": 2237208}, {"id": "0001209191-22-029115", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122029115/0001209191-22-029115-index.htm", "trade_date": "2022-05-12", "timestamp": "2022-05-12", "mins": 2355288}, {"id": "0001209191-22-029321", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Martin Babler", "who_key": "Babler Martin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122029321/0001209191-22-029321-index.htm", "trade_date": "2022-05-12", "timestamp": "2022-05-12", "mins": 2355288}, {"id": "0001209191-22-029323", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Erin Lavelle", "who_key": "Lavelle Erin", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122029323/0001209191-22-029323-index.htm", "trade_date": "2022-05-12", "timestamp": "2022-05-12", "mins": 2355288}, {"id": "0001209191-22-029324", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sarah B. Noonberg", "who_key": "Noonberg Sarah B.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122029324/0001209191-22-029324-index.htm", "trade_date": "2022-05-12", "timestamp": "2022-05-12", "mins": 2355288}, {"id": "0001209191-22-029325", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Rohan Palekar", "who_key": "PALEKAR ROHAN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122029325/0001209191-22-029325-index.htm", "trade_date": "2022-05-12", "timestamp": "2022-05-12", "mins": 2355288}, {"id": "0001209191-22-026894", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Priti Patel", "who_key": "Patel Priti", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "SELL", "amount": 6748.6068, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Top exec sells $7K of NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122026894/0001209191-22-026894-index.htm", "trade_date": "2022-05-02", "timestamp": "2022-05-02", "mins": 2369688}, {"id": "0001209191-22-018936", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Donna Cochener", "who_key": "Cochener Donna", "role": "General Counsel, SVP Legal", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122018936/0001209191-22-018936-index.htm", "trade_date": "2022-03-14", "timestamp": "2022-03-14", "mins": 2440248}, {"id": "0001209191-22-015479", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Principal Accounting Officer", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122015479/0001209191-22-015479-index.htm", "trade_date": "2022-03-02", "timestamp": "2022-03-02", "mins": 2457528}, {"id": "0001209191-22-016454", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Rohan Palekar", "who_key": "PALEKAR ROHAN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122016454/0001209191-22-016454-index.htm", "trade_date": "2022-03-02", "timestamp": "2022-03-02", "mins": 2457528}, {"id": "0001209191-22-006395", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Priti Patel", "who_key": "Patel Priti", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122006395/0001209191-22-006395-index.htm", "trade_date": "2022-02-01", "timestamp": "2022-02-01", "mins": 2499288}, {"id": "0001209191-22-006398", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Carl Walkey", "who_key": "Walkey Carl", "role": "Senior Vice President", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "President files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122006398/0001209191-22-006398-index.htm", "trade_date": "2022-02-01", "timestamp": "2022-02-01", "mins": 2499288}, {"id": "0001209191-21-053544", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 933550.0, "score": 61.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "NLTX catches the CEO's eye: $934K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/0001209191-21-053544-index.htm", "trade_date": "2021-08-25", "timestamp": "2021-08-25", "mins": 2729688}, {"id": "0001209191-21-049919", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on NLTX \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121049919/0001209191-21-049919-index.htm", "trade_date": "2021-08-03", "timestamp": "2021-08-03", "mins": 2761368}], "recent_buys": [{"id": "0001209191-23-046351", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1463486.7308, "score": 60.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "NLTX lands a director's $1.5M", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123046351/0001209191-23-046351-index.htm", "trade_date": "2023-08-17", "timestamp": "2023-08-17", "mins": 1690008}, {"id": "0001209191-21-053544", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 933550.0, "score": 61.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "NLTX catches the CEO's eye: $934K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/0001209191-21-053544-index.htm", "trade_date": "2021-08-25", "timestamp": "2021-08-25", "mins": 2729688}, {"id": "0001209191-21-038690", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 475354.0, "score": 57.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121038690/0001209191-21-038690-index.htm", "trade_date": "2021-06-04", "timestamp": "2021-06-04", "mins": 2847768}, {"id": "0001638599-20-000993", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 6466000.0, "score": 62.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 3 insiders into NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859920000993/0001638599-20-000993-index.htm", "trade_date": "2020-07-07", "timestamp": "2020-07-07", "mins": 3325848}, {"id": "0001104659-20-043863", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Redmile Group, LLC", "who_key": "Redmile Group, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 2011281.1300000001, "score": 52.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 3 buying NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm", "trade_date": "2020-04-02", "timestamp": "2020-04-02", "mins": 3464088}, {"id": "0000899243-19-029824", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 999994.8, "score": 61.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders now buying NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/0000899243-19-029824-index.htm", "trade_date": "2019-12-20", "timestamp": "2019-12-20", "mins": 3613848}, {"id": "0001638599-19-001057", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 25347352.8, "score": 72.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 4 insiders into NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm", "trade_date": "2019-12-20", "timestamp": "2019-12-20", "mins": 3613848}, {"id": "0000899243-19-023329", "src": "INSIDERS", "ticker": "NLTX", "cik": "1404644", "company": "Neurogene Inc.", "company_raw": "Neoleukin Therapeutics, Inc.", "who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "See Remarks, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 781746.5828, "score": 54.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders now buying NLTX", "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm", "trade_date": "2019-09-11", "timestamp": "2019-09-11", "mins": 3757848}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Baker BROS. Advisors LP", "who_key": "BAKER BROS. ADVISORS LP", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 33276839.5308, "sold": 0, "net": 33276839.5308, "trades": 3, "top_score": 72.0, "lean": "buying", "history": [{"action": "BUY", "amount": 1463486.7308, "date": "2023-08-17", "score": 60.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123046351/0001209191-23-046351-index.htm"}, {"action": "BUY", "amount": 6466000.0, "date": "2020-07-07", "score": 62.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859920000993/0001638599-20-000993-index.htm"}, {"action": "BUY", "amount": 25347352.8, "date": "2019-12-20", "score": 72.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000163859919001057/0001638599-19-001057-index.htm"}], "latest": {"action": "BUY", "amount": 1463486.7308, "date": "2023-08-17", "score": 60.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123046351/0001209191-23-046351-index.htm"}}, {"who": "Jonathan G. Drachman", "who_key": "DRACHMAN JONATHAN G", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 3190645.3828, "sold": 0, "net": 3190645.3828, "trades": 4, "top_score": 61.9, "lean": "buying", "history": [{"action": "BUY", "amount": 933550.0, "date": "2021-08-25", "score": 61.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/0001209191-21-053544-index.htm"}, {"action": "BUY", "amount": 475354.0, "date": "2021-06-04", "score": 57.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121038690/0001209191-21-038690-index.htm"}, {"action": "BUY", "amount": 999994.8, "date": "2019-12-20", "score": 61.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000089924319029824/0000899243-19-029824-index.htm"}, {"action": "BUY", "amount": 781746.5828, "date": "2019-09-11", "score": 54.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000089924319023329/0000899243-19-023329-index.htm"}], "latest": {"action": "BUY", "amount": 933550.0, "date": "2021-08-25", "score": 61.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121053544/0001209191-21-053544-index.htm"}}, {"who": "Redmile Group, LLC", "who_key": "Redmile Group, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 2011281.1300000001, "sold": 0, "net": 2011281.1300000001, "trades": 1, "top_score": 52.3, "lean": "buying", "history": [{"action": "BUY", "amount": 2011281.1300000001, "date": "2020-04-02", "score": 52.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm"}], "latest": {"action": "BUY", "amount": 2011281.1300000001, "date": "2020-04-02", "score": 52.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000110465920043863/0001104659-20-043863-index.htm"}}, {"who": "Carl Walkey", "who_key": "Walkey Carl", "role": "Senior Vice President", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 344256.06, "net": -344256.06, "trades": 21, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 6114.0, "date": "2021-06-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121041814/0001209191-21-041814-index.htm"}, {"action": "SELL", "amount": 6600.0, "date": "2021-06-08", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121039223/0001209191-21-039223-index.htm"}, {"action": "SELL", "amount": 6000.0, "date": "2021-06-04", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121038696/0001209191-21-038696-index.htm"}, {"action": "SELL", "amount": 6000.0, "date": "2021-05-26", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121036057/0001209191-21-036057-index.htm"}, {"action": "SELL", "amount": 6378.000000000001, "date": "2021-05-19", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121035020/0001209191-21-035020-index.htm"}, {"action": "SELL", "amount": 13308.0, "date": "2021-05-12", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121032244/0001209191-21-032244-index.htm"}, {"action": "SELL", "amount": 13560.0, "date": "2021-05-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121030654/0001209191-21-030654-index.htm"}, {"action": "SELL", "amount": 30192.0, "date": "2021-04-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121029342/0001209191-21-029342-index.htm"}, {"action": "SELL", "amount": 7800.0, "date": "2021-04-26", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121028727/0001209191-21-028727-index.htm"}, {"action": "SELL", "amount": 21564.0, "date": "2021-04-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121027971/0001209191-21-027971-index.htm"}, {"action": "SELL", "amount": 21996.0, "date": "2021-04-14", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121027050/0001209191-21-027050-index.htm"}, {"action": "SELL", "amount": 21636.0, "date": "2021-04-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121026153/0001209191-21-026153-index.htm"}, {"action": "SELL", "amount": 7800.0, "date": "2021-04-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121025767/0001209191-21-025767-index.htm"}, {"action": "SELL", "amount": 21528.0, "date": "2021-03-31", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121024707/0001209191-21-024707-index.htm"}, {"action": "SELL", "amount": 28715.940000000002, "date": "2021-03-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121022929/0001209191-21-022929-index.htm"}, {"action": "SELL", "amount": 13632.0, "date": "2021-03-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121021946/0001209191-21-021946-index.htm"}, {"action": "SELL", "amount": 21540.059999999998, "date": "2021-03-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121019776/0001209191-21-019776-index.htm"}, {"action": "SELL", "amount": 21360.06, "date": "2021-03-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121017994/0001209191-21-017994-index.htm"}, {"action": "SELL", "amount": 29652.0, "date": "2021-02-25", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121014513/0001209191-21-014513-index.htm"}, {"action": "SELL", "amount": 30480.0, "date": "2021-02-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121011834/0001209191-21-011834-index.htm"}, {"action": "SELL", "amount": 8400.0, "date": "2021-02-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121008839/0001209191-21-008839-index.htm"}], "latest": {"action": "SELL", "amount": 6114.0, "date": "2021-06-16", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121041814/0001209191-21-041814-index.htm"}}, {"who": "Robert Ho", "who_key": "Ho Robert", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 71556.0089, "net": -71556.0089, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 71556.0089, "date": "2021-03-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121021943/0001209191-21-021943-index.htm"}], "latest": {"action": "SELL", "amount": 71556.0089, "date": "2021-03-17", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919121021943/0001209191-21-021943-index.htm"}}, {"who": "Priti Patel", "who_key": "Patel Priti", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "bought": 0, "sold": 17944.113899999997, "net": -17944.113899999997, "trades": 3, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 2607.7711, "date": "2023-04-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123023100/0001209191-23-023100-index.htm"}, {"action": "SELL", "amount": 8587.735999999999, "date": "2023-02-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123006881/0001209191-23-006881-index.htm"}, {"action": "SELL", "amount": 6748.6068, "date": "2022-05-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122026894/0001209191-22-026894-index.htm"}], "latest": {"action": "SELL", "amount": 2607.7711, "date": "2023-04-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123023100/0001209191-23-023100-index.htm"}}, {"who": "Sean Michael Smith", "who_key": "Smith Sean Michael", "role": "Interim CFO, Prin Acct Off", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 4439.225399999999, "net": -4439.225399999999, "trades": 3, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 818.1432, "date": "2023-08-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123045611/0001209191-23-045611-index.htm"}, {"action": "SELL", "amount": 1980.3151999999998, "date": "2023-02-02", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123006886/0001209191-23-006886-index.htm"}, {"action": "SELL", "amount": 1640.7669999999998, "date": "2022-08-10", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919122045667/0001209191-22-045667-index.htm"}], "latest": {"action": "SELL", "amount": 818.1432, "date": "2023-08-11", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1404644/000120919123045611/0001209191-23-045611-index.htm"}}], "activity": [], "announcements": [{"form": "SCHEDULE 13G", "date": "2026-10-07", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000205", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-10-06", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000058", "price_sensitive": false}, {"form": "4", "date": "2026-10-02", "title": "FORM 4", "accession": "0001606302-26-000007", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001104659-26-097193", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001493152-26-038383", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-14", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003430", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001404644-26-000059", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001404644-26-000056", "price_sensitive": true}, {"form": "4", "date": "2026-07-07", "title": "FORM 4", "accession": "0001543663-26-000017", "price_sensitive": false}, {"form": "4", "date": "2026-07-02", "title": "FORM 4", "accession": "0001543663-26-000015", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001404644-26-000050", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001628280-26-046666", "price_sensitive": false}, {"form": "424B5", "date": "2026-06-30", "title": "Prospectus", "accession": "0001628280-26-046237", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-29", "title": "Material event", "accession": "0001404644-26-000046", "price_sensitive": true}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000010", "price_sensitive": false}, {"form": "4/A", "date": "2026-06-16", "title": "FORM 4/A", "accession": "0001996804-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-06-16", "title": "FORM 3/A", "accession": "0001996804-26-000008", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001404644-26-000044", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-04", "title": "Material event", "accession": "0001404644-26-000040", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-12", "title": "Material event", "accession": "0001404644-26-000038", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-12", "title": "Quarterly report", "accession": "0001404644-26-000037", "price_sensitive": true}, {"form": "4", "date": "2026-05-08", "title": "FORM 4", "accession": "0001543663-26-000013", "price_sensitive": false}, {"form": "4", "date": "2026-05-07", "title": "FORM 4", "accession": "0001934412-26-000006", "price_sensitive": false}, {"form": "144", "date": "2026-05-06", "title": "Notice of proposed sale", "accession": "0001968582-26-000406", "price_sensitive": false}], "performance": {"ticker": "NLTX", "has_prices": false, "summary": null, "buys": [{"who": "BAKER BROS. ADVISORS LP", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 1463486.7308, "date": "2023-08-17", "score": 60.4, "ref_price": null, "return": null}, {"who": "DRACHMAN JONATHAN G", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 933550.0, "date": "2021-08-25", "score": 61.3, "ref_price": null, "return": null}, {"who": "DRACHMAN JONATHAN G", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 475354.0, "date": "2021-06-04", "score": 57.4, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 6466000.0, "date": "2020-07-07", "score": 62.6, "ref_price": null, "return": null}, {"who": "Redmile Group, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2011281.1300000001, "date": "2020-04-02", "score": 52.3, "ref_price": null, "return": null}, {"who": "DRACHMAN JONATHAN G", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 999994.8, "date": "2019-12-20", "score": 61.9, "ref_price": null, "return": null}, {"who": "BAKER BROS. ADVISORS LP", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 25347352.8, "date": "2019-12-20", "score": 72.0, "ref_price": null, "return": null}, {"who": "DRACHMAN JONATHAN G", "person_type": "EXEC", "person_label": "Execs", "role": "See Remarks, Director", "amount": 781746.5828, "date": "2019-09-11", "score": 54.3, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}